KCND3 and epilepsy: Since the epileptic phenotype appears to manifest prior to cardiac events in this mutation carrier, identifying <i>KCND3</i> mutations in patients with epilepsy and providing optimal therapy will help prevent sudden unexpected death in epilepsy.